|
|
|
|
| LEADER |
01306nam a2200277 u 4500 |
| 001 |
EB001888764 |
| 003 |
EBX01000000000000001052125 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200106 r ||| eng |
| 020 |
|
|
|a 9781473129191
|
| 245 |
0 |
0 |
|a Lyme disease
|h Elektronische Ressource
|c National Institute for Health and Care Excellence
|
| 260 |
|
|
|a London
|b National Institute for Health and Care Excellence
|c 2018, 11 April 2018©2019
|
| 300 |
|
|
|a 1 PDF file (44 pages)
|
| 653 |
|
|
|a Lyme Disease / diagnosis
|
| 653 |
|
|
|a United Kingdom
|
| 653 |
|
|
|a Lyme Disease / drug therapy
|
| 653 |
|
|
|a Anti-Bacterial Agents / therapeutic use
|
| 710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
| 710 |
2 |
|
|a National Guideline Centre (Great Britain)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a NICE guideline
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK542111
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease
|